Table 2.
Procedure details and Outcomes of overall population and of subgroups according to the occurrence of AKI.
| A: Overall Population | B: AKI,n = 12 | C: No AKI, n = 48 | P value (B vs C) | |
|---|---|---|---|---|
| Procedure details | ||||
| Procedure time – min | 114.5 (SD 32.14) | 135.9 (SD 34.0) | 109.5 (SD 29.9) | 0.03 |
| SBP at the beginning of intervention – mmHg | 136.3 (SD 17.9) | 143.1 (SD 20.2) | 135.0 (SD 17.4) | 0.24 |
| Renal parameters | ||||
| Creatinine post OP - umol/L | 1.29 (0.66–3.85) | 1.76 (1.13–3.19) | 1.26 (0.66–3.85) | <0.01 |
| GFR post OP - ml/min/1.73 m2 | 40 (11–113) | 27 (14–113) | 41 (11–88) | <0.01 |
| Biochemical analysis | ||||
| Hemoglobin post OP – g/dl | 12.6 (7.3–13.9) | 11.6 (7.6–14.2) | 13.0 (7.3–13.9) | 0.05 |
| LOS and Mortality | ||||
| LOS – days | 3 (2–28) | 12 (4–28) | 3 (2–11) | < 0.001 |
| 12 month mortality (all cause) - % | 7 (11.7) | 3 (25) | 4 (8.3) | 0.10 |
| 12 month mortality (cardiac) - % | 3 (5) | 1 (8.3) | 2 (4.2) | 0.55 |
ACE Angiotensine converting enzyme, ARB angiotensin receptor blocker, CABG coronary artery by-pass grafting, AKI acute kidney injury, GFR glomerular filtration rate, LOS length of in-hospital stay, NT-proBNP N-terminal prohormone of brain natriuretic peptide, NYHA New York Heart Association, SBP systolic blood pressure.